ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:1903361;protein localization to basolateral plasma membrane;6.0;1.0;0.8231203125901445;9.628524252492122;65.42666064804821;7.8311634786251565;0.002189771451718415;0.7236063770733796;[CAV1]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[NLRP12, NLRP7, NLRP3, CCL19]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[OXTR, WBP2, CAV1, THBS1, RELA]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[PDGFRB, SMG1, CD80, IMPAD1, ZFYVE21, PIK3C3, MET, VAV1, HBEGF]
GO:1900016;negative regulation of cytokine production involved in inflammatory response;8.0;1.0;0.875;9.628524252492122;227.00494280179373;7.379178354882098;0.007597651144391222;0.7523715242355574;[CUEDC2, NLRP7]
GO:0048754;branching morphogenesis of an epithelial tube;6.0;0.7436939687323844;0.6949672969563367;8.8813098506619;51.7127811195946;4.956792062075433;0.0017307802455913577;0.5766108891590862;[MYC, TIMELESS, KRAS, MET, RASIP1]
GO:0042532;negative regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1231.6194323740242;7.379178354882098;0.041221194016031935;0.8098004765652196;[PPP2CA, CAV1]
GO:0003057;regulation of the force of heart contraction by chemical signal;8.0;0.7436939687323844;0.7468469843661922;8.992535485772125;28.25379719464655;7.9853141584524145;9.456291653381902E-4;0.7833693374183408;[CAV1]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[AGPAT5, SFRP1, COL24A1, XRCC5, HOXB4, MIXL1]
GO:0000188;inactivation of MAPK activity;13.0;0.8436909121759173;0.8844004208555951;9.558319993818873;2610.871803759405;6.518977089658987;0.08738352963975493;0.7959357562962344;[PPP2CA, DUSP22, DUSP5, CAV1, DUSP14]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, ITPR2, RORA, THBS1, AQP3, TM9SF4, HSP90B1, AQP1, NPEPPS, ALKBH5, CCNB1, MYC, NPPA, LMNA, UBQLN1, EP300, SCAP, ATP7A, CREBBP, EGLN2, ENDOG, ITGA2, CAV1, ARNT, SIRT2, SFRP1, TBL2, DDIT4, HYOU1, KCNK3]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[ZNF175, NAB1, GFI1, GMNN, ARID4A, IKZF1, IKZF2, YY1, MYC, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZNF282, ZBTB32, RUNX2, EID1, ILF3, SFRP1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, HOXB4, TIMELESS, PPID, MAX, FOXG1, SUPT6H, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, UBE2I, XRCC5, WFS1, NONO, CAV1, H3F3A, NFKB1, CDK5, CNOT1, PKIA, SP3, BCL3, CDK2, ZNF658, NFE2L3, EZH2, CDKN1C, USP36, CIITA, BTG2, YWHAB, OTUD7B, BRCA1, FLCN, NIPBL, C1QBP, LRRFIP1, HIF1AN, CIC, DACT1, ZNF485, TSC22D4, HELLS, KLF12, PEG3, ARID1A, SIRT2, DUSP22, NCOR1, RBL1, TFDP2, NFX1, MTF2, DEPDC1, LCOR, MCPH1, HDAC3, ZNF350, HDAC1, LRP8, RELA, ARNTL, BCLAF1, RXRA, MTA2, E2F7, ZNF189, E2F8, IRX1, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, TAF7, LIMS1]
GO:0051001;negative regulation of nitric-oxide synthase activity;7.0;1.0;0.8509193652572005;9.628524252492122;123.18001952109483;7.8311634786251565;0.0041227243985507795;0.7514054297404357;[CAV1]
GO:0071375;cellular response to peptide hormone stimulus;7.0;0.7369933605727446;0.7194160455435727;9.117698628726131;386.0268190343683;4.727217620430932;0.012919970231498398;0.5926694942041391;[ERRFI1, XBP1, MAX, CAV1, CRHR1, TSHR, NFKB1, RELA, RAP1B, SP1, MARS, PPAT, RAB13, CSK, RAB8B]
GO:0072584;caveolin-mediated endocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;8.16763571524637;9.517765291732001E-4;0.7408135829017477;[CAV1]
GO:0033137;negative regulation of peptidyl-serine phosphorylation;10.0;0.8933024483968273;0.861892236059334;9.56398573135455;780.3281191277907;6.518977089658987;0.026116879897493853;0.7486218033895181;[CAV1, DDIT4, PAQR3]
GO:0050713;negative regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;999.3037873052855;7.379178354882098;0.033445798446087804;0.8098004765652196;[NLRP7, NLRP3]
GO:0030301;cholesterol transport;7.0;0.7763722522362496;0.7391054913753253;8.999915593069748;37.84975072563126;5.845247994956144;0.0012667970942227542;0.6498456195510879;[STARD3, CAV1]
GO:0031116;positive regulation of microtubule polymerization;10.0;0.8933024483968273;0.861892236059334;9.589303539338841;431.61701704611926;6.518977089658987;0.014445833130437288;0.7486218033895181;[FES, MAPRE1, MET, CLASP1]
GO:0032206;positive regulation of telomere maintenance;8.0;0.7586651285174919;0.754332564258746;9.398000593880289;504.2289052561267;5.8650506222523235;0.0168760876823695;0.6749389615747303;[XRCC5, PNKP, GNL3]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[RAB3B, NCKAP1, OXTR, DGKD, DGKA, CD80, SIRPG, IL5RA, DEFB1, IGF1R, RAB43, RPS6KA4, DOCK11, RPS6KA2, MYC, ARHGDIB, CFL1, ARL6IP5, EP300, SNIP1, NEK1, GTSE1, IFNAR2, PDGFRB, IGFBP5, PAQR3, ERN1, BCR, NISCH, DEPDC1B, KARS, DDIT4, ELMO1, KPNB1, CARD11, DIABLO, CLEC16A, ITPR2, RASGRP2, KRCC1, CRHR1, RASGRP4, STK3, RAP1B, ABR, NUAK1, CCNB1, RHOT2, RHOT1, ZMAT1, RRAS, TBXA2R, STK38, TP53BP2, DVL3, STK38L, MBP, RIPK1, ECT2, RAB6A, MARK2, CCR10, XBP1, SETDB1, EIF2AK3, IFT122, CNOT10, RAB27B, NFKB1, SETX, NFKBIA, CNOT4, CNOT6, IRAK1BP1, COL1A2, PTPRA, CNOT1, GNAQ, RCAN3, BCL3, CNOT3, CDK2, NMUR1, CALM3, CNOT8, CALM1, RGL1, CALM2, BCAR3, BTG2, CDKN1A, MCTP1, PRKCSH, MAST3, YWHAB, DOCK8, ATP2A2, BRCA1, BBC3, POLB, FLCN, AKAP13, AKAP11, NKIRAS1, C1QBP, CASP2, CTSH, HRAS, RAB8B, CCR2, DUSP5, KSR1, SPHK1, OXSR1, TMEM173, MASTL, GFRA2, SPTB, SIRT2, VAV1, CIT, ITPKB, GAL, TFDP1, ALS2, TFDP2, DEPDC1, TAX1BP3, PIK3C3, LCP2, ARHGEF1, LCP1, DOCK2, MET, ARHGEF5, EXOC1, HBEGF, PCNA, ROCK2, TANK, RELA, RAB21, PPP2CA, FZR1, GNG2, RAB20, PABPN1, CCL5, PERP, TIFA, MKNK2, NCAM1, ZNF622, RAB28, BID, E2F7, E2F8, MAP3K3, ARFGEF2, CCL20, TSHR, RAB11A, SNRK, ITCH, P2RX4, TNIP2, CAMK4, RAB13, TAOK2, RAB18, CCM2, KRAS, CAMK1, ASB3, TJP2]
GO:0015787;UDP-glucuronic acid transmembrane transport;9.0;1.0;0.896240625180289;9.628524252492122;193.84528962621604;9.777073627680469;0.006487827394355003;0.896240625180289;[SLC35D1]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[BCAR3, IL6, CAV1, CAMK1, GFRA2]
GO:0070836;caveola assembly;7.0;1.0;0.8509193652572005;9.628524252492122;77.9983017477017;8.390779266560578;0.002610532965581378;0.7800242071602487;[CAV1]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[SLC12A2, KCNK6, KCND1, SLC9A6, KCNK12, KCNA3, PKD2L1, ATP1B2, KCNN3, KCNK3, AQP1]
GO:0060355;positive regulation of cell adhesion molecule production;5.0;1.0;0.7902410118609202;9.628524252492122;40.679961272662325;8.390779266560578;0.0013615216942077584;0.7193458537639684;[COLEC12, CAV1]
GO:0098909;regulation of cardiac muscle cell action potential involved in regulation of contraction;6.0;1.0;0.8231203125901445;9.628524252492122;24.09825301254981;7.697632086000634;8.065468413103714E-4;0.7167775754447168;[CAV1, ATP2A2]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[COLEC12, CRTC2, DGKD, ITLN1, KCNA3, PKD2L1, NLRC4, CLYBL, ACACA, GLS, SPAST, RXRA, RNF213, PPAT, RIPK1, ECT2, BID, VASP, POLQ, PDCD6IP, KCND1, FCER1G, TOR1A, CAV1, ATPIF1, EIF2AK3, KCTD5, MARCKS, ALDH5A1, RAD51, P2RX4, KCTD10, IMPDH2, KCTD14, CHMP4B, ALDOA]
GO:1900027;regulation of ruffle assembly;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;51.76168527241457;6.444869117505266;0.001732417023575362;0.7045909063862833;[CAV1, FAM98A, HRAS]
GO:0006730;one-carbon metabolic process;3.0;0.8933024483968273;0.6447715367885581;9.292052015870908;26.874295102004712;6.518977089658987;8.994584717687482E-4;0.5315011041187423;[AHCYL1, MTHFD1L, MTHFD1, ATPIF1, MTHFD2L, ALDH1L2]
GO:0045019;negative regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;660.5757278387367;7.292166977892469;0.022108875131204346;0.747921758369865;[CAV1]
GO:0032836;glomerular basement membrane development;5.0;0.8933024483968273;0.736892236059334;9.405380701177911;30.929431176690045;7.474488534686424;0.0010351802268029372;0.6724867031240476;[COL4A4]
GO:0048012;hepatocyte growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.292166977892469;0.0010376185600805164;0.747921758369865;[MET, SIRT2]
GO:0051497;negative regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;338.83785420150645;6.781341354126479;0.01134059804585365;0.7792270645443136;[PPFIA1, MET, CLASP1]
GO:0071360;cellular response to exogenous dsRNA;7.0;1.0;0.8509193652572005;9.628524252492122;172.52541059605554;7.069023426578259;0.005774270229860956;0.7124295520356204;[COLEC12, CAV1, TMEM173]
GO:0015718;monocarboxylic acid transport;8.0;0.5640623033008358;0.6570311516504179;7.75672207559053;50.19664702939052;4.879233827729558;0.0016800366020243219;0.6245242448576669;[SLC5A6, PLA2G12A, RXRA, ABCC2, CPT2, STARD10, SLC16A6, SLC25A20, SLC27A2, ACACA, SLC16A14]
GO:0098903;regulation of membrane repolarization during action potential;8.0;0.7307253602413294;0.7403626801206646;9.223059144383958;69.05931417682642;7.697632086000634;0.0023113530961506984;0.7686572628545723;[CAV1]
GO:0086091;regulation of heart rate by cardiac conduction;8.0;1.0;0.875;9.628524252492122;61.172773623059015;6.193554689224359;0.002047397681241798;0.6917386748366816;[CAV1]
GO:0086098;angiotensin-activated signaling pathway involved in heart process;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;56.25645059859106;9.083926447120524;0.0018828527740163208;0.8154717862087246;[CAV1]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[PDGFRB, IGFBP5, C1QBP, CD80, CCL19, THBS1, MET, VAV1, STK3, HBEGF, MTDH]
GO:0071526;semaphorin-plexin signaling pathway;6.0;0.811012628672052;0.7286266269261705;9.089527751759436;26.50247477320489;6.166155715036245;8.87013979980389E-4;0.6384578026126634;[SEMA6B, MET]
GO:0035024;negative regulation of Rho protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;340.00127024396755;6.832634648514029;0.011379536533788362;0.7646622655359331;[FLCN, MET]
GO:2000382;positive regulation of mesoderm development;5.0;0.7369933605727446;0.6587376921472925;8.741221057491218;40.442058373699695;8.16763571524637;0.0013535592982781878;0.7079342821725234;[MIXL1]
GO:0009258;10-formyltetrahydrofolate catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;1382.076842234969;9.083926447120524;0.04625686812119998;0.8607930461318132;[ALDH1L2]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[CDKN1A, DIABLO, CIB1, BRCA1, KRCC1, BBC3, POLB, TFPT, SGPL1, ZMAT1, BAG3, PERP, MKNK2, DPF2, ARL6IP5, TP53BP2, CASP2, EP300, RIPK1, IL12A, ZNF622, BID, HRAS, XBP1, EYA2, PARP2, CD70, CAV1, G0S2, TNFRSF10A, ERN1, P2RX4, BCL3, DDIT4]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[OXTR, PPAT, CAV1, CAD, ATP7A, USF2, NME1]
GO:0042310;vasoconstriction;8.0;0.7508913569872202;0.7504456784936101;9.102431156595342;39.67967046252893;6.343086423195323;0.0013280428609958766;0.6993857346658935;[BBS2, CAV1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, MAML1, CCNH, GFI1, ARID4A, RORA, IKZF1, IKZF2, ELK1, YY1, RPS6KA4, MYC, DPF2, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, FLCN, NIPBL, HRAS, ZNF485, KLF13, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, MET, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, RXRA, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIA, NFIB, TNIP2, NFIC, PSMC1, TAF7, CAMK1, MIXL1]
GO:0060546;negative regulation of necroptotic process;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;152.26887968422463;7.379178354882098;0.0050963023699362245;0.728290889492758;[CAV1]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[OXTR, YWHAB, IL5RA, RASGRP4, PABPN1, CCL5, MYC, CTSH, NCAM1, MBP, RIPK1, HRAS, PDGFRB, MAP3K3, DUSP5, KSR1, PAQR3, GFRA2, SPTB, NFKB1, SETX, ITPKB, KARS, PTPRA, TNIP2, TAOK2, CCM2, KRAS, CALM1, MET, HBEGF]
GO:0001886;endothelial cell morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;48.55088654993496;7.292166977892469;0.0016249544798652153;0.7238411236270654;[COL4A4, MET]
GO:0019065;receptor-mediated endocytosis of virus by host cell;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;100.58356338669144;8.67846133901236;0.0033664413472225267;0.7947362817240173;[CAV1]
GO:2000811;negative regulation of anoikis;8.0;1.0;0.875;9.628524252492122;103.9210822679579;6.943860283624253;0.0034781451006065307;0.7301093378270707;[PTRH2, CAV1]
GO:0006816;calcium ion transport;8.0;0.6696747006330769;0.7098373503165385;8.690254613899192;35.67391733828006;4.3132418226548594;0.001193973908871026;0.5955793873968269;[ATP13A1, CAV1, CACNA2D3, ITPR2, ATP2A2, PKD2L1, TRPC4AP, CORO1A, BSPRY, P2RX4, CDK5, CCL5, NMUR1, CCL19]
GO:0033235;positive regulation of protein sumoylation;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;527.5986379842258;7.379178354882098;0.017658251605384992;0.7926125360964777;[UBE2I, ARNT, GNL3]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD80, CAV1, CTLA4, CSK, PDCD1, PDCD1LG2, CCL19, VAV1, CARD11]
GO:0044860;protein localization to plasma membrane raft;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;66.52527293671452;8.390779266560578;0.002226541016333207;0.7800242071602487;[CAV1]
GO:1904886;beta-catenin destruction complex disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;38.04764185170599;6.7325511899570465;0.0012734203321220245;0.6345439928109722;[CAV1, DVL3]
GO:1901533;negative regulation of hematopoietic progenitor cell differentiation;7.0;0.8259837884571596;0.7639112594857803;9.427853557029971;278.9004260348175;7.8311634786251565;0.009334546265297826;0.7514054297404357;[MIXL1]
GO:0048550;negative regulation of pinocytosis;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;174.57219107609745;8.16763571524637;0.005842774130545118;0.7926932703116032;[CAV1]
GO:0001937;negative regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.36028873802138;6.193554689224359;0.002923870244906099;0.6676580400938822;[CAV1, ATPIF1, THBS1]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[GYPA, WDR1, DOCK8, ITGB3, ITGB2, SIRPG, CD99L2, LYST, CORO1A, GLG1, CCL5, NCKAP1L, CCL19, CCR2, HSD3B7, FCER1G, CCL20, CAV1, TNFRSF10A, ATP1B2, VAV1, NLRP12, IL6, COL1A2, SDC1, CD244, ARHGEF5]
GO:2001238;positive regulation of extrinsic apoptotic signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.54514264355307;358.11284317915005;5.8650506222523235;0.011985714580571521;0.6961795867550195;[SFRP1, CAV1, G0S2, RIPK1, BID, THBS1, STK3]
GO:0010524;positive regulation of calcium ion transport into cytosol;12.0;0.811012628672052;0.8536266269261705;9.4949928598676;446.85811756486936;5.825829909099042;0.01495593904869991;0.7460535250702665;[CD4, P2RX4, CAV1, CALM3, CALM1, CALM2, NTSR1]
GO:0034157;positive regulation of toll-like receptor 7 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;505.2767808384828;9.083926447120524;0.01691115913508416;0.8607930461318132;[TREML4]
GO:0030512;negative regulation of transforming growth factor beta receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.537552474286395;374.7458266990886;5.54296712308321;0.012542405570270547;0.6584675964488075;[ONECUT2, SNX25, CAV1, GLG1]
GO:0019217;regulation of fatty acid metabolic process;6.0;0.6181399273706679;0.6321902762754785;8.375761283996754;59.641021377846656;5.407625775213448;0.001996131312082062;0.599666546214876;[ELOVL5, CAV1, SCAP, LONP2, ERLIN2, BRCA1, ADIPOR2]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[PDGFRB, IL5RA, ERLIN2, CLK4, CLK3, IGF1R, CLK1, BCR, WEE1, ZMYM2, FES, TRIM24, NEK1, CSK, EPHA1, MET, HBEGF]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[PPP2CA, GNL3L, DTX3L, CDK5, EPB41, CAV1, EP300, TMEM173, MAPRE1, DACT1, STK3]
GO:0030193;regulation of blood coagulation;7.0;0.6696747006330769;0.685756715573739;8.935377071932177;65.68414019264287;5.420364800990877;0.0021983890603594525;0.628117073252615;[FGA, FCER1G, FAP, TBXA2R, CAV1, FGG, PLAUR, CD9, THBS1]
GO:0061099;negative regulation of protein tyrosine kinase activity;11.0;0.8653626801206646;0.8651102923899945;9.55953138100517;2158.5537617243776;6.481236761676141;0.07224485183265184;0.7638797017301124;[ERRFI1, CAV1, CHMP6]
GO:0046655;folic acid metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.551563211355994;318.75190525379287;6.7325511899570465;0.010668339410754122;0.6952223462072524;[MTHFD1L, MTHFD1, MTHFD2L, ALDH1L2]
GO:0006641;triglyceride metabolic process;7.0;0.8436909121759173;0.7727648213451592;9.318369324188282;85.59385656069774;5.500407508664414;0.0028647493496168257;0.6322104610454062;[FABP5, GPAM, CAV1, MGLL]
GO:1903206;negative regulation of hydrogen peroxide-induced cell death;9.0;0.8436909121759173;0.8180860812682478;9.589303539338841;500.078557460717;6.8867018697843045;0.01673717927672765;0.7484268790654467;[HSPH1, PYCR1, MET]
GO:0008543;fibroblast growth factor receptor signaling pathway;8.0;0.7090535922965819;0.729526796148291;8.567652291806858;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[SETX, TIAL1, POLR2B, POLR2G, SHCBP1]
GO:0009236;cobalamin biosynthetic process;6.0;0.8933024483968273;0.7697715367885581;9.566003895510788;630.4116379868331;8.67846133901236;0.021099310189779532;0.7669372290569613;[MMACHC]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[ZNF175, ONECUT2, ELL, CCNH, INTS10, ARID4A, HOXC13, BRCA1, ELK1, AFF4, MYC, TRIM24, ZNF768, EP300, IER2, GTF2I, TBP, KLF13, MKL1, ZBTB32, ARNT, CREB3, NCOR1, TFDP1, TFDP2, ELF4, IRF4, NFX1, RFX4, TFEC, MED20, LCOR, WBP2, MAX, RPAP1, SUPT6H, GTF2E2, RELA, ARNTL, POLR2B, RAD21, TAF1A, HLTF, HIVEP1, HOXC4, POLR2G, HIVEP2, TFAP2A, POLR2J3, ZBTB17, ZNF143, XBP1, NFYC, INTS3, PBX3, EAF2, ARID3B, DEK, GRHL1, USF2, GTF2H4, FLI1, NFKB1, CDK9, GFI1B, STAG1, TFCP2, COPS5, NFIA, SP1, NFIB, NFIC, MAFF, NFE2L3, INTS4, TAF7, INTS7, MNAT1, NFE2L1, MIXL1]
GO:1904816;positive regulation of protein localization to chromosome, telomeric region;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;74.11254383842964;7.292166977892469;0.002480480145313119;0.7238411236270654;[GNL3L, GNL3]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[GNL3L, CAV1, TFIP11, CAMK1, ADNP, SENP2, MET, DACT1]
GO:0006488;dolichol-linked oligosaccharide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;80.91159753301743;7.069023426578259;0.00270803835371991;0.6846304993685643;[ALG9, ALG14, ALG2, ALG1]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ERRFI1, RABGAP1, DOCK8, RASGRP2, RIC8A, ABR, DOCK11, ARHGAP21, RGS1, CCL5, ARHGDIB, DVL3, NCKAP1L, EVI5L, CCL19, ECT2, A2M, TBC1D22A, HRAS, STARD13, SEC13, CCL20, TBC1D8, TBC1D2B, ARHGAP25, VAV1, ARFGAP1, BCR, DEPDC1B, SFRP1, ALS2, TBC1D20, GNAQ, RUNDC1, DEPDC1, RAB3GAP2, PKP4, TAX1BP3, ARHGEF1, DOCK2, EPHA1, ARHGEF5, RAB3GAP1, EZH2, LIMS1]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[PDGFRB, HSD3B7, FCER1G, CCL20, ITGB2, LYST, CORO1A, VAV1, IL6, CCL5, RAB13, NCKAP1L, CCL19, ARHGEF5, CCR10, CCR2, HBEGF]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[BECN1, CALCOCO2, ITGB4, EI24, CLEC16A, PTPN22, FNBP1L, CLN3, LAMP2, VPS11, UBQLN1, C6orf106, MARK2, VPS18, GABARAPL1, XBP1, VTA1, PGA3, DYNLL2, PRKAB1, PGA5, SIRT2, TM9SF1, VPS41, CHMP4B, PIK3C3, CHMP6]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[FANCI, RNF20, WFS1, SPHK1, CAV1, PTPN22, BRCA1, SENP2, MASTL, UBE2L3, CDK9, FZR1, UBQLN1, SKP2]
GO:0033577;protein glycosylation in endoplasmic reticulum;8.0;0.9326813400603323;0.8413406700301662;9.574457031221845;176.5615275388073;9.083926447120524;0.005909355431665436;0.839552420951524;[ALG2]
GO:0035635;entry of bacterium into host cell;7.0;1.0;0.8509193652572005;9.628524252492122;28.374411874040543;7.697632086000634;9.496660301113433E-4;0.7445766281117727;[MET]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[TLE4, CSNK2A1, UBE2B, USP34, KLHL12, SENP2, APCDD1, DDB1, SFRP1, GNG2, GNAT2, CCNE1, MYC, AP2S1, DVL3, SDC1, TAX1BP3, CALM1, MET, MARK2, CSNK1G2, DACT1, CSNK1G1]
GO:0071455;cellular response to hyperoxia;6.0;1.0;0.8231203125901445;9.628524252492122;99.6623809530134;7.8311634786251565;0.0033356102001776892;0.7236063770733796;[CAV1]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[PER2, GNL3L, DTX3L, CDK5, RPS7, U2AF2, CAV1, GLMN, FBXO5, SENP2, MAD2L1]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, CCL20, SPHK1, EIF2AK3, ATP2A2, DEFB1, P2RX4, RCAN3, NMUR1, CALM3, CALM1, CALM2, CCR10, CCR2]
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;9.0;0.7671156992804218;0.7797984748205;9.413412872875176;596.4251749563025;5.75172193694532;0.019961813857978603;0.6903839525180965;[BCLAF1, FBXO18, RPS7, CAV1, SERINC3, BID]
GO:0055129;L-proline biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;721.3825385994909;8.16763571524637;0.024144024364789993;0.8501222226412654;[PYCR1]
GO:2000312;regulation of kainate selective glutamate receptor activity;10.0;1.0;0.9152410118609203;9.628524252492122;462.3570184446122;8.67846133901236;0.0154746733130397;0.8590579283277371;[NETO2]
GO:0034141;positive regulation of toll-like receptor 3 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;505.2767808384828;7.8311634786251565;0.01691115913508416;0.7967266896635242;[CAV1, PTPN22]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[OXTR, AHCYL1, DGKD, DGKA, DEFB1, HEBP1, AKAP13, GPR132, GNAT2, RGS1, ADORA3, NPPA, OR56B1, HOMER3, CCR2, PDGFRB, SPHK2, SPHK1, VAV1, SFRP1, GAL, ARHGEF1, DAGLB, GPRC5D, ARHGEF5, SUCNR1, ROCK2, IQGAP2, CRHR1, RIC8A, C3, ABR, GNG2, TBXA2R, CCL5, CCL19, ECT2, NTSR1, CCR10, SLC12A2, CCL20, CAV1, GPR55, TSHR, GPR180, GNAQ, GNB2, NMUR1, CALM3, CALM1, CALM2]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[SFRP1, TBL1XR1, CAV1, USP34, NFKB1, ARNTL, DACT1]
GO:1903609;negative regulation of inward rectifier potassium channel activity;12.0;1.0;0.9481203125901445;9.628524252492122;1503.7936590381803;9.777073627680469;0.050330620441580154;0.9481203125901445;[CAV1]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[SFRP1, CLEC3B, CAV1, SOX6, LIMS1]
GO:0030857;negative regulation of epithelial cell differentiation;6.0;0.6634067003016617;0.6548236627409754;8.638125548464245;143.89713366415532;6.139487467954083;0.004816107564726769;0.6370939872166814;[CAV1, EZH2]
GO:0042074;cell migration involved in gastrulation;6.0;0.8259837884571596;0.7361122068187242;9.089527751759436;22.57397290845719;7.212124270218933;7.555305579894227E-4;0.6919486831672181;[RIC8A, MIXL1]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[CRTC2, ZNF175, NCF1, MAML1, CCNH, GFI1, CD80, EIF4A3, ARID4A, RORA, IKZF1, GPATCH3, IKZF2, ELK1, YY1, RPS6KA4, MYC, ZXDC, DPF2, TRIM24, EP300, SOX8, SOX6, IER5, ZNF564, IER2, RPS9, RPS7, FLT3LG, PRKAB1, MED6, RUNX2, PIAS2, ERN1, ARMCX3, OLFM1, ILF3, SFRP1, KARS, IL23A, TBL1XR1, CCNE1, RFX4, HOXB4, MAX, NOLC1, RLF, SUPT6H, C3, FXR1, CCNB1, HSPH1, RAD21, HLTF, DVL3, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, RHBDD1, CAV1, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, CDKN1C, CIITA, SETD3, ONECUT2, ELL, PTPN22, DDX41, HOXC13, BRCA1, AATF, WDR43, CKS1B, FLCN, NIPBL, LBH, C1QBP, NUP62, TMED2, CTSH, HRAS, ZNF485, SEC13, TBP, KLF13, PEG3, DTX3L, NCOA6, ITGA2, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, ARID1A, SIRT2, GNL3, CREB3, GAL, NCOR1, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, POLR1E, MET, HDAC3, ZNF350, HDAC1, WBP2, ROCK2, POLDIP3, THBS1, RELA, ARNTL, SERTAD3, BCLAF1, CLEC3B, RXRA, U2AF2, SERTAD2, TP53INP2, CCL5, TP53INP1, LMNA, TAF1A, POLR2G, GPBP1L1, MTA2, E2F7, E2F8, TBX1, RNF20, ZNF462, CHURC1, YTHDF3, NFYC, ATAD2, ARID3B, DEK, GRHL1, USF2, CD4, NFIA, NFIB, TNIP2, NFIC, CAMK4, MARS, PSMC1, TAF7, KRAS, CAMK1, FAM98A, RAB3GAP1, MIXL1, LIMS1]
GO:0010507;negative regulation of autophagy;7.0;0.7436939687323844;0.7227663496233927;9.117698628726131;217.48068666745357;5.500407508664414;0.007278882862848883;0.6322104610454062;[BECN1, USP36, HERC1, CLEC16A, CHMP4B, PTPN22, MET, SIRT2, RASIP1, EIF4G2]
GO:0072657;protein localization to membrane;5.0;0.5756379274792419;0.5780599756005412;7.585450354983161;29.829169826127035;3.7017275965917853;9.983554695705216E-4;0.4795475332985618;[RAB3B, TRAM1, SYS1, RPL3, NCF1, ROCK2, ITGB2, ZDHHC23, SRP54, ZDHHC24, ZDHHC6, ABCA12, TRAM2, TM9SF4, RPS15, TMED2, BID, RAB8B, RPL19, PEX16, BBS2, UBL4A, GRIPAP1, RPS9, PEX19, FCER1G, RPS7, SSR2, CAV1, RAB3IP, IFT122, RPL23A, RAB11A, GAK, TM9SF1, CDK5, SLMAP, RAB13, TAOK2, CHMP4B, RAB3GAP2, RPL29, VAMP5, RAB3GAP1]
GO:0035987;endodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;6.444869117505266;7.050676185779127E-4;0.5795909063862833;[ITGB2, MIXL1]
GO:2000286;receptor internalization involved in canonical Wnt signaling pathway;8.0;1.0;0.875;9.628524252492122;66.79409571189065;8.67846133901236;0.0022355382726935618;0.8188169164668168;[CAV1]
GO:0006065;UDP-glucuronate biosynthetic process;8.0;1.0;0.875;9.628524252492122;847.4108547704801;8.67846133901236;0.028362078688912176;0.8188169164668168;[UGDH, SLC35D1]
GO:1905246;negative regulation of aspartic-type peptidase activity;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;499.6307270806722;8.67846133901236;0.016722190796928726;0.8590579283277371;[NLRP7]
GO:0045907;positive regulation of vasoconstriction;8.0;0.8933024483968273;0.8216512241984136;9.57973408832269;103.52331479149503;6.280566066213989;0.003464832181136806;0.6961884407023742;[FGA, OXTR, TBXA2R, CAV1, FGG]
GO:0046952;ketone body catabolic process;5.0;0.8933024483968273;0.736892236059334;9.517298617381897;195.6316577686379;8.390779266560578;0.006547615528454911;0.7193458537639684;[OXCT2]
GO:1902895;positive regulation of pri-miRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1721.2385553242598;6.599019797332524;0.0576083054325737;0.7855944919115336;[RELA, GNL3]
GO:0001570;vasculogenesis;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;5.6339389012889365;7.050676185779127E-4;0.5381198974168686;[SGPL1, CAV1, GLMN, CCM2, RASIP1]
GO:1901844;regulation of cell communication by electrical coupling involved in cardiac conduction;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;47.34252427509125;7.57984905034425;0.0015845116819816402;0.7626338329336335;[CAV1, CALM3, CALM1, CALM2]
GO:0061436;establishment of skin barrier;8.0;1.0;0.875;9.628524252492122;44.874432655588755;6.781341354126479;0.0015019068766151408;0.7217981122146513;[ABCA12, GRHL1, MET]
GO:0030206;chondroitin sulfate biosynthetic process;8.0;1.0;0.875;9.628524252492122;416.1007025877491;6.558197802812269;0.013926516049292044;0.7103865406232063;[CHPF, SLC35D1, CHST12]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[CIITA, BTG2, ZNF175, GFI1, OTUD7B, IKZF2, YY1, FLCN, NIPBL, C1QBP, MYC, SAP130, WWC3, EP300, SOX8, LRRFIP1, HIF1AN, CIC, SOX6, ZNF564, DACT1, TLE4, KLF12, PEG3, ZBTB32, ARID1A, SIRT2, DUSP22, EID1, BRMS1, NCOR1, RBL1, TBL1XR1, CCNE1, NFX1, MTF2, HOXB4, TIMELESS, LCOR, PPID, MCPH1, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, RELA, MTDH, RXRA, BAG3, TPR, HIVEP1, HESX1, SUDS3, MTA2, E2F7, ZNF189, E2F8, BPTF, IRX1, TFAP2A, DR1, CREBBP, UBE2I, WFS1, CAV1, NFKB1, PER2, GFI1B, NFIA, CNOT1, NFIB, NFIC, PKIA, SP3, CDK2, NFE2L3, TAF7, EZH2]
GO:0001960;negative regulation of cytokine-mediated signaling pathway;7.0;0.7140352122741334;0.7079369713942671;8.965230035081857;244.80256319284138;5.8067817141283475;0.008193321482061134;0.6478784521606894;[IL6, HIST1H2BJ, CCL5, CAV1, RFFL]
GO:0032507;maintenance of protein location in cell;5.0;0.6763753087927167;0.6284286662572787;8.412128928167629;43.86076268124676;5.4730085344763;0.0014679802548176633;0.5701309228349632;[CD4, CDK5, GPAA1, CAV1, BCL3]
GO:0010955;negative regulation of protein processing;9.0;0.7192862368539868;0.7558837436072825;9.27570287786938;707.1969765737138;6.039404009397101;0.023669246369964203;0.705096027081865;[NLRP7, NLRC4, A2M, UBE2Z, THBS1, GLG1]
GO:0010952;positive regulation of peptidase activity;9.0;0.7140352122741334;0.7532582313173557;9.377209824211215;435.08389316762396;4.595290077388384;0.014561866354238107;0.6312439734407735;[PRELID1, DIABLO, ROCK2, CAV1, EIF2AK3, TNFRSF10A, NLRC4, HSPE1, TANK, BBC3, NLRP12, KARS, PERP, MYC, ARL6IP5, PSME2, NLRP3, CTSH, MBP, RIPK1, BID]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[SERPINA3, CSTB, SERPINB1, CSTA, ITIH2, CSNK2A1, AMBP, SERPINA10, PLAUR, TNFRSF10A, NLRC4, UBE2Z, THBS1, SERPINB6, AQP1, VIL1, C3, NLRP7, RFFL, A2M]
GO:2001028;positive regulation of endothelial cell chemotaxis;10.0;0.8933024483968273;0.861892236059334;9.55953138100517;483.0357984563073;7.138016298065211;0.01616677347033737;0.7802794972956796;[P2RX4, MET]
GO:0098911;regulation of ventricular cardiac muscle cell action potential;10.0;0.7866048967936545;0.8085434602577476;9.537552474286395;102.35229487303722;7.138016298065211;0.0034256391983155283;0.7802794972956796;[CAV1]
GO:0033674;positive regulation of kinase activity;9.0;0.6073376606709605;0.6999094555157693;8.620883742029738;265.89784403492143;3.4106031799490317;0.008899361547325376;0.5706590304121504;[CDKN1A, NCF1, CCNH, ITGB3, KIF14, CIB1, IGF1R, CKS1B, AKAP13, NEK1, HRAS, PDGFRB, DUSP5, ZFP91, OXSR1, MAPK8IP3, ERN1, KARS, ALS2, IL23A, JTB, LCP2, ADNP, EPHA1, MET, ARHGEF5, VAC14, LRP8, THBS1, STK3, PPP2CA, CCNB1, HSPH1, CCL5, DVL3, NCKAP1L, RIPK1, CSK, ZNF622, CCL19, ECT2, MARK2, MAP3K3, PDE6H, XRCC5, TNFRSF10A, PILRB, CENPE, CD4, CDK5, TAOK2, KRAS, CALM3, CAMK1, CALM1, MNAT1, CALM2, EZH2]
GO:1900085;negative regulation of peptidyl-tyrosine autophosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;1790.2607340613608;9.777073627680469;0.05991841563897651;0.9324289523296623;[CAV1]
GO:1905098;negative regulation of guanyl-nucleotide exchange factor activity;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;99.11376152007192;8.16763571524637;0.003317248401482572;0.7408135829017477;[MET]
GO:1903598;positive regulation of gap junction assembly;7.0;1.0;0.8509193652572005;9.628524252492122;133.85571530024345;8.67846133901236;0.004480030328776454;0.7947362817240173;[CAV1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[ZNF175, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SND1, EID1, EWSR1, RFX4, HOXB4, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, RPAP1, ZNF25, RAD21, HLTF, HIVEP1, HESX1, HOXC4, HIVEP2, ZNF264, ZNF143, XBP1, SETDB1, ZNF260, XRCC5, INTS3, PBX3, EAF2, FLI1, SOX30, STAG1, ZNF30, INTS4, INTS7, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, INTS10, ATF7IP2, HOXC13, BRCA1, WDR43, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, ZNF485, TSC22D4, HELLS, COMMD3, BAZ1A, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF350, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, GPBP1L1, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, NFIC, MARS, ZNF696, MIXL1, CRTC2, NAB1, ARID4A, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZBTB32, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, NONO, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZNF658, NFE2L3, CNOT8, TMEM18, MNAT1, ZNF532, ZNF410, NFE2L1, PHF19, CIITA, ONECUT2, CHD1, AFF4, LBH, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, LRRFIP1, HIF1AN, KLF12, TBP, KLF13, BUD31, MKL1, ARNT, SAFB, ARID1A, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, LCOR, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2G, ASCC3, E2F7, ZNF189, E2F8, TBX1, POLR2J3, CHURC1, EYA2, ARID3B, DEK, USF2, POLR3C, TNIP2, POLR3E, TAF7, MNDA]
GO:1901299;negative regulation of hydrogen peroxide-mediated programmed cell death;10.0;0.8933024483968273;0.861892236059334;9.59462270081644;688.8496181578963;7.9853141584524145;0.023055176795337348;0.8236103492792612;[HSPH1, MET]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[OXTR, CAV1, GPR55, ITPR2, CD4, P2RX4, GNAT2, TBXA2R, CALM3, CCL19, CALM1, CALM2, NTSR1, CCR10, CCR2]
GO:0090090;negative regulation of canonical Wnt signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;236.99226377157444;4.932886541221878;0.00793191778924446;0.6272680471207706;[TLE4, SFRP1, HDAC1, CAV1, DVL3, KLHL12, DACT1, STK3]
GO:0009617;response to bacterium;5.0;0.7508913569872202;0.6656866903545304;8.935377071932177;27.267803904038782;3.9481280100702625;9.126288572378991E-4;0.49214846190264216;[ANKRD17, FGA, FCER1G, SEH1L, HIST1H2BJ, PPP1R11, CCL20, CAV1, DEFB1, IL27, RNASE3, NLRC4, LYST, VIL1, CD4, IL6, IL23A, BCL3, NLRP3, IL12A, HIST1H2BC, HAVCR2]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[UPF1, XBP1, ABCC2, CCL20, GFI1, CD80, PDCD1LG2, NFKB1, RELA, BCR, IL6, PABPN1, NLRP7, TBXA2R, TNIP2, NLRP3, IL12A, HAVCR2]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CCL20, CCL5, CIB1, CCL19, CCR10, CCR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, DEFB1, IL27, LYST, PPP6C, C1QBP, HAVCR2, FGA, FCER1G, DTX3L, WRNIP1, RNASE3, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, NLRC4, ZC3HAV1, LILRA2, CORO1A, RELA, C2, C3, PRDX1, SLAMF7, NLRP3, CSK, APOL1, APOBEC3F, APOBEC3H, XRCC5, NONO, NFKB1, ITCH, POLR3C, FES, TREML4, POLR3E, PTX3, SERINC3, TRIM32, CD244, APOBEC3A, C1QC]
GO:0006749;glutathione metabolic process;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;147.28945980206763;5.71663061713405;0.0049296456676673804;0.6154690682008903;[GSTK1, GSTA5, ALDH5A1, CTNS, CHAC2, MMACHC]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[CIB1, UBE2Z, IGF1R, AQP1, MYC, CFL1, SOX8, IER3, PDGFRB, CSNK2A1, FLT3LG, THOC6, SFRP1, CFDP1, VDAC2, ADNP, EPHA1, PPID, CORO1A, MTDH, HSP90B1, HSPH1, BAG3, BAG1, NCKAP1L, RIPK1, NTSR1, TFAP2A, PRELID1, XBP1, UBE2B, WFS1, NONO, RHBDD1, CAV1, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, IL6, SON, COPS5, BCL3, HYOU1, MNAT1, CPEB4, AVEN, BTG2, CDKN1A, DOCK8, KIF14, BRCA1, AATF, NUP62, CASP2, CTSH, HRAS, TSC22D4, FGA, DFFA, FCER1G, SPHK2, SPHK1, FGG, PLAUR, YWHAZ, DDB1, ITPKB, CREB3, PTRH2, MET, BECN1, HDAC3, HDAC1, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL19, RFFL, SNCB, BID, TBX1, EYA2, SYVN1, ITCH, GPAM, TNIP2, KRAS, ERCC5, PDCD1, TRIM32, MAD2L1]
GO:0070495;negative regulation of thrombin-activated receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;238.42697029648212;8.67846133901236;0.007979936125481077;0.8188169164668168;[MET]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PDGFRB, FGA, CCL20, FGG, GPR55, CIB1, PTPN22, IGF1R, RAP1B, CD4, KARS, CCL5, CCL19, EPHA1, HRAS, MET, HAVCR2]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[UPF1, ABCC2, CCL20, FGG, RORA, TANK, NFKB1, RELA, YY1, SFRP1, NLRP7, CCL5, CCL19]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[ITGB3, CDC7, CORO1A, MET, TM9SF4, UNC13D]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[BECN1, PCNA, NCF1, TXNRD1, GPX7, ATP2A2, PYCR1, VRK2, SIRT2, RELA, AQP1, SETX, IL6, CCS, PRDX1, TP53INP1, PXMP2, CDK2, ECT2, NFE2L1, EZH2]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[NCKAP1, WDR1, EPB41, ROCK2, WIPF2, ARPC1A, CORO1A, AQP1, ABR, CFL1, NCKAP1L, PDGFRB, PDCD6IP, KIF23, BCR, VIL1, NISCH, MKLN1, DIAPH3, PARVG, CDK5, RAB13, TAOK2, ELMO1, KRAS, DOCK2, TRIM32, ARHGEF5, PAFAH1B1]
GO:1903071;positive regulation of ER-associated ubiquitin-dependent protein catabolic process;12.0;1.0;0.9481203125901445;9.628524252492122;6504.6704340352835;7.8311634786251565;0.2177054656038327;0.8486063770733797;[CAV1, UBQLN1]
